Intelligence Β· Clinical Pipeline
Chinese Academy of Pipeline
All ClinicalTrials.gov programs at Chinese Academy of β phase, modality, and trial IDs.
- Programs
- 1,328
Quick answer
Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Leflunomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ANCA Associated Vasculitis
1 trial -
Letrozole -Berberine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polycystic Ovary Syndrome
1 trial -
Lidocaine Hydrochloride 2% Injection Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Losartan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Luo-Fu-Shan Plaster
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Arthritis, Rheumatoid
1 trial -
Luvometinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis (LCH)
1 trial -
Medical Treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Artery Stenting
1 trial -
Medical treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Decompensated Cirrhosis
1 trial -
Meiji Yogurt Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
H. Pylori Infection
1 trial -
Metformin pretreatment before ovarian stimulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metformin
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Multi-component Interventions
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
Multi-component intervention package
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multimorbidity
1 trial -
N-butyl-2-cyanoacrylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Varices
1 trial -
Nadroparin Calcium and Warfarin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cirrhosis
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Norepinephrine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypotension
1 trial -
Nutrilite Protein MetX Pro
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Nutritional therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
OSS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bowel Preparation
1 trial -
Oliceridine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypoxemia During Surgery
1 trial -
Omega-3
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Adhd
1 trial -
Only conventional drug therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Artery Hypertension
1 trial -
Oral Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
2 trials -
Oral supplementation of vitamin D
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mental Health Wellness 1
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postpartum Hemorrhage
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Social Behavior
1 trial -
PCSK9 inhibitor (PCSK9i)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
PGS 2.0
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Recurrent Pregnancy Loss
1 trial -
Paclitaxel Oral Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small-Cell Lung Cancer
1 trial -
Papillary epinephrine spraying
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis
1 trial -
Partially Hydrolyzed Whey Protein Formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mild Allergic Symptoms in Infants
1 trial -
Photo-responsive nanozyme
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Phytosterols & placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-alcoholic Fatty Liver Disease
1 trial -
Pitavastatin and placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Placebo 1 to Probiotic A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Dysfunction
1 trial -
Placebo plus high-intensity statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Polyethylene glycol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Postoperative radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Tongue Squamous Cell Carcinoma
1 trial -
Prebiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Undifferentiated Connective Tissue Disease
1 trial -
Pregabalin capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia
1 trial -
Prepackaged Low-residue diet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colon Polyp
1 trial
Frequently asked questions
How many pipeline programs does Chinese Academy of have?
1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs